The first domestically produced proton therapy system was approved by the State Drug Administration on September 26, 2022 for marketing. This is an important achievement under the "Digital Diagnostic and Treatment Equipment Special Project", a key research and development program of the Ministry of Science and Technology during the "13th Five-Year Plan" period. This product is the first proton therapy system approved with superconducting cyclotron technology and a 360-degree rotating rack, whose technical features make the product compact and can realize multi-angle treatment, and at the same time, under the premise of guaranteeing the treatment effect of the patients, it can effectively shorten the treatment time of the patients.
The approval of this product marks another important step in the localization of China's high-end medical equipment. It is of great significance to enhance the means and level of medical tumor diagnosis and treatment in China. In addition, the product is mainly used for the treatment of systemic solid malignant tumors and certain benign diseases, which brings new hope to patients with malignant tumors.
Overall, the approval of the first domestic proton therapy system is an important milestone in the localization of China's medical equipment, and has a significant impact on enhancing the technical level and quality of medical services in China's medical field.